AAAAAA

   
Results: 1-3 |
Results: 3
Elective withdrawal of mycophenolate mofetil in renal transplant recipients treated with mycophenolate mofetil, cyclosporine, and prednisone
Authors: ter Meulen, CG Gregoor, PJHS Weimar, W Hilbrands, LB
Citation: Cg. Ter Meulen et al., Elective withdrawal of mycophenolate mofetil in renal transplant recipients treated with mycophenolate mofetil, cyclosporine, and prednisone, TRANSPLAN I, 14(2), 2001, pp. 99-102
Two doses of daclizumab are sufficient for prolonged interleukin-2R alpha chain blockade
Authors: ter Meulen, CG Baan, CC Hene, RJ Hilbrands, LB Hoitsma, AJ
Citation: Cg. Ter Meulen et al., Two doses of daclizumab are sufficient for prolonged interleukin-2R alpha chain blockade, TRANSPLANT, 72(10), 2001, pp. 1709-1710
The influence of mycophenolate mofetil on the incidence and severity of primary cytomegalovirus infections and disease after renal transplantation
Authors: ter Meulen, CG Wetzels, JFM Hilbrands, LB
Citation: Cg. Ter Meulen et al., The influence of mycophenolate mofetil on the incidence and severity of primary cytomegalovirus infections and disease after renal transplantation, NEPH DIAL T, 15(5), 2000, pp. 711-714
Risultati: 1-3 |